Dianthus Therapeutics (DNTH) Misses Q4 EPS by 81c

Dianthus Therapeutics (NASDAQ: DNTH) reported Q4 EPS of ($0.81). Revenue for the quarter came in at $1.33 million.

For earnings history and earnings-related data on Dianthus Therapeutics (DNTH) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Rubio says Iran cannot charge tolls in Strait of Hormuz
• UK’s EG Group reportedly files for US IPO worth about $1 billion